Feasibility of a walking programme for people with symptoms of hip/knee osteoarthritis

• Conditions: Osteoarthritis; Physical Medicine / Rehabilitation - Physiotherapy; Musculoskeletal - Osteoarthritis

• Registration Number: ACTRN12615001101572
• Lead Sponsor: Centre for Health, Activity and Rehabilitation Research, School of Physiotherapy, University of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-10-20
• Study Completion: 2018-02-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

All potential participants aged 40-75 years who satisfy American College of Rheumatology clinical criteria for classification of hip/knee OA will be considered for inclusion. Additionally participants should not be regularly physically active (less than 7500 steps/day), but able to walk for at least 10 minutes will only be considered for the study.

Exclusion Criteria

Participants will be excluded if they had undergone any hip/knee surgery within the past 12 months, have a history of lower limb joint replacement, have had an intra-articular steroid injection within the past 12 months, have history of inflammatory/systemic arthritis. Participants with a hip/knee joint pain from a source other than the respective joint (confirmed by clinical examination) will also be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adherence to the intervention: Adherence to the intervention programme will be evaluated from the exercise diary and pedometer logs.[At 6 weeks (conclusion of the intervention programme) and at 12 weeks.];Percentage of recruitment, retention and attrition to the intervention. <br>This is a composite primary measure of feasibility to assess the ability to recruit required sample size, ability to retain the recruited sample during the intervention phase and the ability to follow-up at least 90% of the participants. <br>The study records will reviewed at the end of the study to determine the percentages.[At 12 weeks.];Acceptability of the intervention: Acceptability will be determined by a survey exploring participants’ opinions at the completion of the study (after 12 weeks) using a five point numerical scale. <br>Any adverse events due to the intervention will also be recorded and evaluated. [At 12 weeks]

Secondary Outcome Measures

Name	Time	Method
Physical activity levels:<br>Objective physical activity will be measured using Yamex Ex210 Pedometers.<br>Subjective physical activity will be measured using the New Zealand Physical Activity Questionnnaire[At baseline, 6-weeks and 12 weeks.];Exercise self-efficacy:<br>The 12-item exercise confidence questionnaire to determine the self-efficacy towards physical activity.[At baseline, 6-weeks and 12-weeks.];Western Ontario and McMaster Universities Arthritis Index (WOMAC): A condition-specific assessment tool that has the sensitivity to quantify small effects of an intervention.[At baseline, 6-weeks and 12-weeks.]